Crossmark

Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity

Crossref DOI link: https://doi.org/10.1186/s13395-020-00227-4

Published Online: 2020-04-11

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jones, Takako I.

Chew, Guo-Liang

Barraza-Flores, Pamela

Schreier, Spencer

Ramirez, Monique

Wuebbles, Ryan D.

Burkin, Dean J.

Bradley, Robert K.

Jones, Peter L.
Funding

Funding for this research was provided by:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR070432, R21NS086902)

FSHD Society (22061-02)

Muscular Dystrophy Association (383364)

The Chris Carrino Foundation for FSHD

National Institute of Neurological Disorders and Stroke (P01NS069539)
License Information

Text and Data Mining valid from 2020-04-11

Version of Record valid from 2020-04-11
More Information

Article History

Received: 21 February 2020

Accepted: 5 March 2020

First Online: 11 April 2020

Ethics approval and consent to participate

: All animal procedures were approved by the local IACUC committee at the University of Nevada, Reno (#0701).

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below